domstat.net
biospace.com
MENU
last data update: 2024/09/10, 07:49
Website loading time
during the test: 0.18 s
cable connection (average): 1.79 s
DSL connection (average): 3.41 s
modem (average): 88.76 s
HTTP headers
HTTP/1.1 301 Moved Permanently
Server: awselb/2.0
Date: Tue, 10 Sep 2024 14:49:42 GMT
Content-Type: text/html
Content-Length: 134
Connection: close
Location: https://biospace.com:443/
HTTP/1.1 301 Moved Permanently
Date: Tue, 10 Sep 2024 14:49:42 GMT
Content-Length: 0
Connection: close
server: istio-envoy
strict-transport-security: max-age=31536000; includeSubDomains
location: https://www.biospace.com/
vary: Accept-Encoding
x-envoy-upstream-service-time: 22
x-envoy-decorator-operation: brightspot-cms-verify.biospace.svc.cluster.local:80/*
HTTP/1.1 200 OK
Content-Type: text/html;charset=UTF-8
Connection: close
Date: Tue, 10 Sep 2024 14:49:41 GMT
Server: istio-envoy
strict-transport-security: max-age=31536000; includeSubDomains
x-powered-by: Brightspot
x-envoy-upstream-service-time: 784
x-envoy-decorator-operation: brightspot-cms-verify.biospace.svc.cluster.local:80/*
Vary: Accept-Encoding
X-Cache: Hit from cloudfront
Via: 1.1 165ed32c12154887fba331169c8022ee.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: IAD50-C2
X-Amz-Cf-Id: VJQRc9pyZGhVu87zSMrWogyZTmJOE9QMkAmZ1nub0-YSq2LLC7zVlA==
Age: 1
Information about DNS servers
| biospace.com | NS | ns-1742.awsdns-25.co.uk | IN | 79785 | |
| biospace.com | NS | ns-943.awsdns-53.net | IN | 79785 | |
| biospace.com | NS | ns-1202.awsdns-22.org | IN | 79785 | |
| biospace.com | NS | ns-152.awsdns-19.com | IN | 79785 |
Received from the first DNS server
Request to the server "biospace.com"
Truncated, retrying in TCP mode.
Request to the server "biospace.com"
You used the following DNS server:
DNS Name: ns-1742.awsdns-25.co.uk
DNS Server Address: 205.251.198.206#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 62454
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 0
REQUEST SECTION:
biospace.com. IN ANY
ANSWER SECTION:
biospace.com. 300 IN A 15.197.236.53
biospace.com. 172800 IN NS ns-1202.awsdns-22.org.
biospace.com. 172800 IN NS ns-152.awsdns-19.com.
biospace.com. 172800 IN NS ns-1742.awsdns-25.co.uk.
biospace.com. 172800 IN NS ns-943.awsdns-53.net.
biospace.com. 900 IN SOA ns-943.awsdns-53.net. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400
biospace.com. 300 IN MX 0 biospace-com.mail.protection.outlook.com.
biospace.com. 300 IN TXT "google-site-verification=A47P05237iUhTB9QQKLTvoq-lXoYL94arBsI2g2kMQA"
biospace.com. 300 IN TXT "google-site-verification=KeLHoPzQAvbfKC02AQs09FFWhNnZlN7ChGz07zYaJZ8"
biospace.com. 300 IN TXT "google-site-verification=V2L6hfTI3_91H5p9zQ6w96jrzRYsdFMxqrz_TQzCpKw"
biospace.com. 300 IN TXT "google-site-verification=necj6Bc6lAy7cD2CUkZW1w-uMKk3qu-NvW1W628Bk8I"
biospace.com. 300 IN TXT "google-site-verification=x9MAcWtDdCjWIAU38DN-WrcOUZ4U_De0am0zY31kQOk"
biospace.com. 300 IN TXT "hj=1434561-07192024"
biospace.com. 300 IN TXT "v=spf1 include:spf.loxo.co include:spf.protection.outlook.com include:_spf.salesforce.com include:4413123.spf05.hubspotemail.net -all"
Received 880 bytes from address 205.251.198.206#53 in 16 ms
Received from the second DNS server
Request to the server "biospace.com"
Truncated, retrying in TCP mode.
Request to the server "biospace.com"
You used the following DNS server:
DNS Name: ns-943.awsdns-53.net
DNS Server Address: 205.251.195.175#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 5492
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 0
REQUEST SECTION:
biospace.com. IN ANY
ANSWER SECTION:
biospace.com. 300 IN A 15.197.236.53
biospace.com. 172800 IN NS ns-1202.awsdns-22.org.
biospace.com. 172800 IN NS ns-152.awsdns-19.com.
biospace.com. 172800 IN NS ns-1742.awsdns-25.co.uk.
biospace.com. 172800 IN NS ns-943.awsdns-53.net.
biospace.com. 900 IN SOA ns-943.awsdns-53.net. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400
biospace.com. 300 IN MX 0 biospace-com.mail.protection.outlook.com.
biospace.com. 300 IN TXT "google-site-verification=A47P05237iUhTB9QQKLTvoq-lXoYL94arBsI2g2kMQA"
biospace.com. 300 IN TXT "google-site-verification=KeLHoPzQAvbfKC02AQs09FFWhNnZlN7ChGz07zYaJZ8"
biospace.com. 300 IN TXT "google-site-verification=V2L6hfTI3_91H5p9zQ6w96jrzRYsdFMxqrz_TQzCpKw"
biospace.com. 300 IN TXT "google-site-verification=necj6Bc6lAy7cD2CUkZW1w-uMKk3qu-NvW1W628Bk8I"
biospace.com. 300 IN TXT "google-site-verification=x9MAcWtDdCjWIAU38DN-WrcOUZ4U_De0am0zY31kQOk"
biospace.com. 300 IN TXT "hj=1434561-07192024"
biospace.com. 300 IN TXT "v=spf1 include:spf.loxo.co include:spf.protection.outlook.com include:_spf.salesforce.com include:4413123.spf05.hubspotemail.net -all"
Received 880 bytes from address 205.251.195.175#53 in 1 ms
Subdomains (the first 50)
Typos (misspells)
| viospace.com niospace.com hiospace.com giospace.com buospace.com bjospace.com bkospace.com boospace.com b9ospace.com b8ospace.com biispace.com bikspace.com bilspace.com bipspace.com bi0space.com bi9space.com bioapace.com biozpace.com bioxpace.com biodpace.com bioepace.com | biowpace.com biosoace.com bioslace.com bios-ace.com bios0ace.com biospzce.com biospsce.com biospwce.com biospqce.com biospaxe.com biospave.com biospafe.com biospade.com biospacw.com biospacs.com biospacd.com biospacr.com biospac4.com biospac3.com iospace.com bospace.com | bispace.com biopace.com biosace.com biospce.com biospae.com biospac.com ibospace.com boispace.com bisopace.com biopsace.com biosapce.com biospcae.com biospaec.com bbiospace.com biiospace.com bioospace.com biosspace.com biosppace.com biospaace.com biospacce.com biospacee.com |
Location
IP: 15.197.236.53
continent: , country: (), city:
Website value
rank in the traffic statistics:
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 620.06 KB
text per all code ratio: 17 %
title: BioSpace: Biotech, Pharmaceutical and Clinical Research News
description:
keywords:
encoding: UTF-8
language: en-US
Website code analysis
one word phrases repeated minimum three times
| Phrase | Quantity |
|---|---|
| Drug | 5 |
| News | 5 |
| to | 5 |
| and | 4 |
| Jobs | 4 |
| Press | 4 |
| Releases | 4 |
| 2024 | 3 |
| Search | 3 |
| Submit | 3 |
two word phrases repeated minimum three times
three word phrases repeated minimum three times
B tags
U tags
I tags
BioSpace
images
headers
H1
H2
H3
H4
H5
H6
internal links
| address | anchor text |
|---|---|
| https://www.biospace.com/news | News |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/fda | FDA |
| https://www.biospace.com/drug-delivery | Drug Delivery |
| https://www.biospace.com/deals | Deals |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/policy | Policy |
| https://www.biospace.com/cell-and-gene-therapy | Cell and Gene Therapy |
| https://www.biospace.com/weight-loss | Weight Loss |
| https://www.biospace.com/rare-diseases | Rare Disease |
| https://www.biospace.com/cancer | Cancer |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/artificial-intelligence | Artificial Intelligence |
| https://www.biospace.com/nextgen | NextGen Class of 2024 |
| https://www.biospace.com/insights/ | Insights |
| https://www.biospace.com/podcasts | Podcasts |
| https://www.biospace.com/reports | Reports |
| https://www.biospace.com/webinars | Webinars |
| https://www.biospace.com/search-press-releases | Press Releases |
| https://www.biospace.com/latest-news-press-releases | All News & Releases |
| https://jobs.biospace.com/searchjobs/ | Jobs |
| https://www.biospace.com/career-advice | Career Advice |
| https://www.biospace.com/companies | Companies |
| https://www.biospace.com/hotbeds | Hotbeds |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/best-places-to-work | Best Places to Work |
| https://employer.biospace.com/pricing/ | Post Jobs |
| https://www.biospace.com/talent-solutions | Talent Solutions |
| https://www.biospace.com/advertise | Advertise |
| https://www.biospace.com/submit-a-press-release | Submit a Press Release |
| https://www.biospace.com/subscribe-to-newsletters | SUBSCRIBE |
| https://www.biospace.com/subscribe-to-newsletters | SUBSCRIBE |
| https://www.biospace.com/news | News |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/fda | FDA |
| https://www.biospace.com/drug-delivery | Drug Delivery |
| https://www.biospace.com/deals | Deals |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/policy | Policy |
| https://www.biospace.com/cell-and-gene-therapy | Cell and Gene Therapy |
| https://www.biospace.com/weight-loss | Weight Loss |
| https://www.biospace.com/rare-diseases | Rare Disease |
| https://www.biospace.com/cancer | Cancer |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/artificial-intelligence | Artificial Intelligence |
| https://www.biospace.com/nextgen | NextGen Class of 2024 |
| https://www.biospace.com/insights/ | Insights |
| https://www.biospace.com/podcasts | Podcasts |
| https://www.biospace.com/reports | Reports |
| https://www.biospace.com/webinars | Webinars |
| https://www.biospace.com/search-press-releases | Press Releases |
| https://www.biospace.com/latest-news-press-releases | All News & Releases |
| https://jobs.biospace.com/searchjobs/ | Jobs |
| https://www.biospace.com/career-advice | Career Advice |
| https://www.biospace.com/companies | Companies |
| https://www.biospace.com/hotbeds | Hotbeds |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/best-places-to-work | Best Places to Work |
| https://employer.biospace.com/pricing/ | Post Jobs |
| https://www.biospace.com/talent-solutions | Talent Solutions |
| https://www.biospace.com/advertise | Advertise |
| https://www.biospace.com/submit-a-press-release | Submit a Press Release |
| #container-module-2-column-e50011 | |
| #list-module-e50007 | |
| https://www.biospace.com/startups | Startups |
| https://www.biospace.com/business/roivant-creates-new-vant-to-license-bayers-pulmonary-hypertension-drug | Roivant Creates New ‘Vant’ to License Bayer’s Pulmonary Hypertension Drug |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/biosecure-act | BIOSECURE Act |
| https://www.biospace.com/policy/biosecure-act-sails-through-house-passage-lines-up-senate-vote | BIOSECURE Act Sails Through House Passage, Lines Up Senate Vote |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/antibody-drug-conjugate-adc | Antibody-drug conjugate (ADC) |
| https://www.biospace.com/drug-development/astrazeneca-daiichi-sankyos-dato-dxd-fails-to-significantly-improve-overall-survival-in-phase-iii-nsclc | AstraZeneca, Daiichi Sankyo’s Dato-DXd Fails to Significantly Improve Overall Survival in Phase III NSCLC |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/funding | Funding |
| https://www.biospace.com/business/terns-announces-125m-raise-on-heels-of-oral-glp-1-data-drop | Terns Announces $125M Raise on Heels of Oral GLP-1 Data Drop |
| https://www.biospace.com/kate-goodwin | Kate Goodwin |
| https://www.biospace.com/layoffs | Layoffs |
| https://www.biospace.com/biospace-layoff-tracker | Biopharma Layoff Tracker 2024: Vesigen, Connect Biopharma, BioMarin and More Cut Staff |
| https://www.biospace.com/biospace-editorial-staff | BioSpace Editorial Staff |
| https://www.biospace.com/startups | Startups |
| https://www.biospace.com/business/candid-debuts-with-370m-targets-leadership-in-t-cell-engager-space | Candid Debuts With $370M, Targets Leadership in T Cell Engager Space |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/weight-loss | Weight loss |
| https://www.biospace.com/drug-development/terns-shares-climb-as-investigational-glp-1-pill-spurs-5-weight-loss-after-28-days | Terns Shares Climb as Investigational GLP-1 Pill Spurs 5% Weight Loss After 28 Days |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| https://www.biospace.com/fda | FDA |
| https://www.biospace.com/biospace-fda-decision-tracker | FDA Tracker: Travere Secures Full Approval for IgAN Drug Filspari |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| https://www.biospace.com/breast-cancer | Breast cancer |
| https://www.biospace.com/drug-development/relay-scores-early-breast-cancer-win-plans-pivotal-trial-against-astrazenecas-truqap | Relay Scores Early Breast Cancer Win, Plans Pivotal Trial Against AstraZeneca’s Truqap |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/news | More News |
| #featured-stories | |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/drug-development/late-stage-alzheimers-pipeline-goes-beyond-amyloid-and-tau | Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau |
| https://www.biospace.com/gail-dutton | Gail Dutton |
| https://www.biospace.com/cancer | Cancer |
| https://www.biospace.com/drug-development/esmo-2024-preview-bispecifics-and-tigits-among-the-hottest-topics-in-oncology | ESMO 2024 Preview: Bispecifics and TIGITs Among the Hottest Topics in Oncology |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| https://www.biospace.com/sponsored | Sponsored |
| https://www.biospace.com/sino-biologicals-new-center-for-bioprocessing-c4b-us-based-cro-services | Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services |
| #logo-list-module-540000 | |
| https://www.biospace.com/companies | VIEW ALL FEATURED COMPANIES |
| #from-biospace-insights | |
| https://www.biospace.com/policy | Partnered |
| https://www.biospace.com/policy/qara-professionals-question-a-future-with-cybersecurity-issues-us-litigation-and-the-eu-ai-act | QARA Professionals Question a Future with Cybersecurity Issues, US Litigation, and the EU AI Act |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/fda | FDA |
| https://www.biospace.com/news/fda-cber-director-dr-peter-marks-discusses-industry-growth-collaboration-and-communication | FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication |
| https://www.biospace.com/lori-ellis | Lori Ellis |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/with-latest-expansion-in-ohio-resilience-can-best-serve-partners-and-patients | With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/report-the-state-of-diversity-equity-inclusion-and-belonging-in-life-sciences | Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/a-takeda-oncology-leader-s-passion-fuels-a-patient-first-approach | A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/policy | Policy |
| https://www.biospace.com/can-12-billion-jumpstart-women-s-health | Can $12 Billion Jumpstart Women’s Health? |
| https://www.biospace.com/lori-ellis | Lori Ellis |
| https://www.biospace.com/policy | Policy |
| https://www.biospace.com/global-healthcare-celebrates-tech-successes-and-grapples-with-cybersecurity-at-himss-2024 | Global Healthcare Celebrates Tech Successes & Grapples with Cybersecurity at HIMSS 2024 |
| https://www.biospace.com/lori-ellis | Lori Ellis |
| https://www.biospace.com/insights/ | Read More |
| #listen | |
| https://www.biospace.com/podcasts | Podcast |
| https://www.biospace.com/business/lillys-dtc-obesity-push-layoffs-and-an-eye-on-ocular-diseases | Lilly’s DTC Obesity Push, Layoffs, and an Eye on Ocular Diseases |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/drug-development/future-proofing-inclusive-and-protective-patient-strategies | Future-Proofing: Inclusive and Protective Patient Strategies |
| https://www.biospace.com/lori-ellis | Lori Ellis |
| https://www.biospace.com/podcasts | Podcast |
| https://www.biospace.com/business/a-tough-ending-new-beginnings-and-china-u-s-biopharma-relations | A Tough Ending, New Beginnings and China-U.S. Biopharma Relations |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| ?p=2 | Load More |
| #subscribe-to-genepool | |
| #special-editions | |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/job-trends/2024-q2-job-market-report-more-people-competing-for-fewer-job-openings | 2024 Q2 Job Market Report: More People Competing for Fewer Job Openings |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/deals | Deals |
| https://www.biospace.com/deals/deep-dive-biopharma-m-a-activity-picks-up-steam | Deep Dive: Biopharma M&A Activity Picks Up Steam |
| https://www.biospace.com/jef-akst | Jef Akst |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/deep-dive-psychedelics-for-mental-health | Deep Dive: Psychedelics for Mental Health |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| ?p=2 | Load More |
| #container-module-3-column-ea000f | |
| #partnerships-alliances | |
| https://www.biospace.com/deals | Deals |
| https://www.biospace.com/deals/lilly-haya-ink-potential-1b-drug-discovery-deal-to-target-obesity-and-metabolic-conditions | Lilly, Haya Ink Potential $1B Drug Discovery Deal to Target Obesity and Metabolic Conditions |
| https://www.biospace.com/kate-goodwin | Kate Goodwin |
| https://www.biospace.com/mergers-acquisitions | Mergers & acquisitions |
| https://www.biospace.com/deals/broken-deals-4-pharma-assets-returned-to-biotech-this-year | Broken Deals: 4 Pharma Assets Returned to Biotech This Year |
| https://www.biospace.com/mollie-barnes | Mollie Barnes |
| https://www.biospace.com/mergers-acquisitions | Mergers & acquisitions |
| https://www.biospace.com/deals/ucb-offloads-neurology-allergy-portfolio-in-china-for-680m | UCB Offloads Neurology, Allergy Portfolio in China for $680M |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| https://www.biospace.com/deals | Deals |
| https://www.biospace.com/deals/biopharma-vc-funding-in-q2-reaches-highest-quarterly-level-since-2022 | Biopharma VC Funding in Q2 Reaches Highest Quarterly Level Since 2022 |
| https://www.biospace.com/kate-goodwin | Kate Goodwin |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/business/biotech-industry-overcomes-slump-adapts-to-new-normal | Biotech Industry Overcomes Slump, Adapts to New Normal |
| https://www.biospace.com/ana-mulero | Ana Mulero |
| #bankruptcies | |
| https://www.biospace.com/obesity | Obesity |
| https://www.biospace.com/drug-development/amgen-plans-phase-iii-program-for-next-gen-obesity-drug-targeting-liver-and-kidney-diseases | Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/glp-1 | GLP-1 |
| https://www.biospace.com/drug-development/uks-mhra-finds-no-risk-of-suicidal-ideation-self-harm-with-glp-1-drugs | UK’s MHRA Finds No Risk of Suicidal Ideation, Self-Harm With GLP-1 Drugs |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/ipo | IPO |
| https://www.biospace.com/business/lilly-partner-bioage-files-for-ipo-to-advance-obesity-candidate | Lilly Partner BioAge Files for IPO to Advance Obesity Candidate |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/podcasts | Podcast |
| https://www.biospace.com/business/lillys-dtc-obesity-push-layoffs-and-an-eye-on-ocular-diseases | Lilly’s DTC Obesity Push, Layoffs, and an Eye on Ocular Diseases |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| https://www.biospace.com/supply-chain | Supply chain |
| https://www.biospace.com/business/novos-ozempic-to-remain-in-shortage-into-q4-as-supply-woes-continue | Novo’s Ozempic to Remain in Shortage Into Q4 as Supply Woes Continue |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| #earnings-reports | |
| https://www.biospace.com/clinical-research | Clinical research |
| https://www.biospace.com/drug-development/gsk-to-approach-fda-with-positive-phase-iii-data-for-long-acting-asthma-med | GSK to Approach FDA With Positive Phase III Data For Long-Acting Asthma Med |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| https://www.biospace.com/approvals | Approvals |
| https://www.biospace.com/FDA/travere-wins-full-fda-approval-for-igan-treatment-filspari | Travere Wins Full FDA Approval for IgAN Treatment Filspari |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/covid-19 | COVID-19 |
| https://www.biospace.com/FDA/novavax-catches-up-to-competitors-with-fda-approval-for-updated-covid-19-boosters | Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/regulatory | Regulatory |
| https://www.biospace.com/FDA/fda-action-alert-travere-avadel-and-roche | FDA Action Alert: Travere, Avadel and Roche |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/fda | FDA |
| https://www.biospace.com/FDA/opinion-the-fda-needs-a-dedicated-center-for-rare-diseases | The FDA Needs a Dedicated ‘Center for Rare Diseases’ |
| https://www.biospace.com/henry-i-miller | Henry I. Miller |
| #career-hub | |
| #career-hub | |
| https://www.biospace.com/career-advice | Career Advice |
| https://www.biospace.com/career-advice/the-top-12-companies-hiring-in-biopharma-now | The Top 12 Companies Hiring in Biopharma Now |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/career-advice | Career Advice |
| https://www.biospace.com/career-advice/managers-toolbox-how-to-have-difficult-conversations | Manager’s Toolbox: How to Have Difficult Conversations |
| https://www.biospace.com/bruce-wu | Bruce Wu |
| https://www.biospace.com/management | Management |
| https://www.biospace.com/career-advice/stuck-in-the-middle-how-millennial-managers-can-bridge-generational-gaps | Stuck in the Middle: How Millennial Managers Can Bridge Generational Gaps |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/job-trends/difficult-market-turns-more-biopharma-leaders-to-fractional-roles-say-experts | Difficult Market Turns More Biopharma Leaders to Fractional Roles, Say Experts |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/job-trends/massachusetts-biopharma-jobs-grew-at-slowed-rate-in-2023-report | Massachusetts’ Biopharma Jobs Grew at Slowed Rate in 2023: Report |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/government | Government |
| https://www.biospace.com/career-advice/judge-blocks-ftc-rule-that-banned-most-new-noncompete-clauses | Judge Blocks FTC Rule That Banned Most New Noncompete Clauses |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/compensation | Compensation |
| https://www.biospace.com/career-advice/pay-range-transparency-new-law-could-help-massachusetts-biopharma-industry | Pay Range Transparency: New Law Could Help Massachusetts Biopharma Industry |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/leadership | Leadership |
| https://www.biospace.com/career-advice/leadership-lab-5-steps-for-building-your-personal-brand | Leadership Lab: 5 Steps for Building Your Personal Brand |
| https://www.biospace.com/michael-pietrack | Michael Pietrack |
| https://www.biospace.com/layoffs | Layoffs |
| https://www.biospace.com/career-advice/layoff-dilemma-would-you-take-pay-cut-demotion-to-keep-your-job | Layoff Dilemma: Would You Take Pay Cut, Demotion to Keep Your Job? |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/career-advice | MORE CAREER ADVICE |
| #list-module-ec0000 | |
| https://www.biospace.com/biotech-bay | Biotech Bay |
| https://www.biospace.com/biotech-beach | Biotech Beach |
| https://www.biospace.com/genetown | Genetown |
| https://www.biospace.com/pharm-country | Pharm Country |
| https://www.biospace.com/biomidwest | BioMidwest |
| https://www.biospace.com/bioforest | BioForest |
| https://www.biospace.com/biocapital | BioCapital |
| https://www.biospace.com/bio-nc | Bio NC |
| https://www.biospace.com/lone-star-bio | Lone Star Bio |
| #container-module-2-column-a70000 | |
| #best-places-to-work | |
| https://www.biospace.com/best-places-to-work | Best Places to Work |
| https://www.biospace.com/best-places-to-work | View 2024 Winners |
| #in-case-you-missed-it | |
| #in-case-you-missed-it | |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/business/astellas-pharma-opens-cambridge-life-sciences-center-featuring-incubator-space | Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space |
| https://www.biospace.com/angela-gabriel | Angela Gabriel |
| https://www.biospace.com/staff-editorial | Editorial |
| https://www.biospace.com/drug-development/roche-and-sanofi-ms-trials-show-potential-challenges-of-oral-btk-inhibitors | Roche and Sanofi MS Trials Show Potential, Challenges of Oral BTK Inhibitors |
| https://www.biospace.com/greg-slabodkin | Greg Slabodkin |
| https://www.biospace.com/immunology-and-inflammation | Immunology and inflammation |
| https://www.biospace.com/drug-development/gsk-builds-nucalas-copd-case-with-phase-iii-win | GSK Builds Nucala’s COPD Case With Phase III Win |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| #reports | |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/job-trends/report-2024-job-market-trends-h2-update | Report: 2024 Job Market Trends, H2 Update |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/report-the-state-of-diversity-equity-inclusion-and-belonging-in-life-sciences | Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| https://www.biospace.com/job-trends | Job Trends |
| https://www.biospace.com/report-2024-u-s-life-sciences-salary-trends | Report: 2024 U.S. Life Sciences Salary Trends |
| https://www.biospace.com/biospace-insights | BioSpace Insights |
| ?p=2 | Load More |
| #container-module-3-column-5a000f | |
| #money | |
| https://www.biospace.com/lung-cancer | Lung cancer |
| https://www.biospace.com/drug-development/summit-declares-nsclc-victory-over-keytruda-analysts-advise-caution-with-china-only-data | Summit Declares NSCLC Victory Over Keytruda, Analysts Advise Caution With China-Only Data |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/lung-cancer | Lung cancer |
| https://www.biospace.com/drug-development/j-j-challenges-astrazenecas-tagrisso-with-phase-iii-data-for-rybrevant-lazcluze-combo | J&J Challenges AstraZeneca’s Tagrisso With Phase III Data for Rybrevant, Lazcluze Combo |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/antibody-drug-conjugate-adc | Antibody-drug conjugate (ADC) |
| https://www.biospace.com/drug-development/astrazeneca-daiichi-sankyo-turn-to-ai-to-explain-phase-iii-nsclc-miss-for-dato-dxd | AstraZeneca, Daiichi Sankyo Turn to AI to Explain Phase III NSCLC Miss for Dato-DXd |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/manufacturing | Manufacturing |
| https://www.biospace.com/business/novartis-starts-construction-on-two-us-sites-to-bolster-radioligand-therapy-manufacturing | Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/business/arsenalbio-snags-mega-325m-series-c-round-with-backing-from-nvidia-regeneron | ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| #regulatory | |
| https://www.biospace.com/multiple-sclerosis | Multiple sclerosis |
| https://www.biospace.com/drug-development/roche-touts-phase-ii-ms-data-on-heels-of-sanofis-late-stage-stumbles | Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/alzheimers-disease | Alzheimer’s disease |
| https://www.biospace.com/drug-development/athiras-small-molecule-injection-for-alzheimers-flops-in-phase-ii-iii-study | Athira’s Small Molecule Injection for Alzheimer’s Flops in Phase II/III Study |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/neuroscience | Neuroscience |
| https://www.biospace.com/drug-development/recursion-reports-thin-mid-stage-efficacy-data-for-rare-brain-disease-therapy | Recursion Reports Thin Mid-Stage Efficacy Data for Rare Brain Disease Therapy |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/multiple-sclerosis | Multiple sclerosis |
| https://www.biospace.com/drug-development/sanofis-tolebrutinib-misses-two-of-three-late-stage-multiple-sclerosis-readouts | Sanofi’s Tolebrutinib Misses Two of Three Late-Stage Multiple Sclerosis Readouts |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| https://www.biospace.com/drug-development | Drug Development |
| https://www.biospace.com/drug-development/neurocrine-shares-drop-20-despite-meeting-primary-endpoint-in-mid-stage-schizophrenia-trial | Neurocrine Shares Drop 20% Despite Meeting Primary Endpoint in Mid-Stage Schizophrenia Trial |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| #policy | |
| https://www.biospace.com/business | Business |
| https://www.biospace.com/business/biomarin-rolls-out-4b-revenue-expectations-as-analysts-wonder-about-pipeline | BioMarin Rolls Out $4B Revenue Expectations, as Analysts Wonder About Pipeline |
| https://www.biospace.com/annalee-armstrong | Annalee Armstrong |
| https://www.biospace.com/gene-editing | Gene editing |
| https://www.biospace.com/business/gene-editing-patent-landscape-remains-clear-as-mud-say-patent-attorneys | Gene Editing Patent Landscape Remains ‘Clear as Mud,’ Say Patent Attorneys |
| https://www.biospace.com/christoph-schwaiger | Christoph Schwaiger |
| https://www.biospace.com/editorial | Editorial |
| https://www.biospace.com/drug-development/eyes-ears-get-their-due-with-cell-and-gene-therapy | Eyes, Ears Get Their Due With Cell and Gene Therapy |
| https://www.biospace.com/heather-mckenzie | Heather McKenzie |
| https://www.biospace.com/gene-therapy | Gene Therapy |
| https://www.biospace.com/drug-development/beyond-rare-disease-wet-amd-gene-therapy-could-reach-millions | Beyond Rare Disease: Wet AMD Gene Therapy Could Reach Millions |
| https://www.biospace.com/kate-goodwin | Kate Goodwin |
| https://www.biospace.com/collaboration | Collaboration |
| https://www.biospace.com/business/pfizer-partners-with-flagships-quotient-to-leverage-genetics-against-heart-renal-diseases | Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases |
| https://www.biospace.com/tristan-manalac | Tristan Manalac |
| #promo-module-7e0000 | |
| https://www.biospace.com/news | ALL NEWS |
| https://www.biospace.com/news | News |
| https://jobs.biospace.com/searchjobs/ | Jobs |
| https://www.biospace.com/career-advice | Career Advice |
| https://www.biospace.com/subscribe-to-newsletters | Newsletters |
| https://www.biospace.com/podcasts | Podcasts |
| https://www.biospace.com/webinars | Webinars |
| https://www.biospace.com/reports | Reports |
| https://www.biospace.com/companies | Companies |
| https://www.biospace.com/nextgen | NextGen Class of 2024 |
| https://www.biospace.com/best-places-to-work | Best Places to Work |
| https://www.biospace.com/biotech-bay | Biotech Bay |
| https://www.biospace.com/biotech-beach | Biotech Beach |
| https://www.biospace.com/biocapital | BioCapital |
| https://www.biospace.com/biomidwest | BioMidwest |
| https://www.biospace.com/bio-nc | Bio NC |
| https://www.biospace.com/bioforest | BioForest |
| https://www.biospace.com/genetown | Genetown |
| https://www.biospace.com/pharm-country | Pharm Country |
| https://www.biospace.com/lone-star-bio | Lone Star Bio |
| https://www.biospace.com/about-us | About Us |
| https://www.biospace.com/editorial | Editorial |
| https://www.biospace.com/join-our-team | Join Our Team |
| https://www.biospace.com/contact-us | Support |
| https://www.biospace.com/terms-and-conditions | Terms & Conditions |
| https://www.biospace.com/privacy-policy | Privacy Policy |
| https://employer.biospace.com/login | Employer Login |
| https://employer.biospace.com/pricing/ | Post Jobs |
| https://www.biospace.com/talent-solutions | Talent Solutions |
| https://www.biospace.com/employer-resources | Employer Resources |
| https://www.biospace.com/advertise | Advertise |
| https://www.biospace.com/submit-a-press-release | Submit a Press Release |
| https://www.biospace.com/rss-feeds | RSS Feeds |
external links
| address | anchor text |
|---|---|
| https://www.sinobiological.com?utm_source=biospace&utm_medium=article&utm_campaign=sep-c4b-sponsored-content | Sino Biological, Inc. |
| https://www.sinobiological.com/news/c4b-business?utm_source=biospace&utm_medium=article&utm_campaign=sep-c4b-sponsored-content | Center for Bioprocessing (C4B) |